Novartis | The Epoch Times

Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy

Novartis said on Jan. 10 that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep has prompted the firm to exercise an option to in-licence the antiviral from ...

January 10, 2022BY Tom Ozimek

Novartis Says US Court Upholds Gilenya Patent

ZURICH—Novartis AG said on Tuesday a U.S. court of appeals upheld the validity of a dosage regimen patent ...

January 5, 2022BY Reuters

Novartis Options BeiGene Anti-Cancer Therapy in $1 Billion Deal

ZURICH—Novartis has signed an option, collaboration, and license agreement with BeiGene Ltd for anti-cancer therapy ociperlimab (BGB-A1217) to ...

December 21, 2021BY Reuters

Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake

ZURICH—Roche shareholders voted overwhelmingly on Friday to support the $20.7 billion deal to buy Novartis's nearly one third ...

November 27, 2021BY Reuters

Drugmakers Announce Trial of Jakafi for COVID-19 Patients on Ventilators

Two drugmakers plan on testing a drug that blocks enzymes in COVID-19 patients on ventilators in the United States. ...

May 6, 2020BY Zachary Stieber

Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19

Swiss drugmaker Novartis gained permission from the U.S. Food and Drug Administration to test hydroxychloroquine, a malaria drug ...

April 20, 2020BY Zachary Stieber

Novartis Korea Executives Charged With Bribing Doctors

Prosecutors have indicted a former chief executive of the South Korean unit of Novartis and five other former ...

August 13, 2016BY The Associated Press

New Drug Could Reduce Cardiovascular Deaths (Video)

The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs.

August 30, 2014BY Epoch Video